No Data
No Data
Jim Cramer Says Analysts Like Salesforce.com Inc. (CRM)'s 'Artificial Intelligence Optionality'
Notable Analyst Calls This Week: Microsoft, Starbucks and GM Among Top Picks
Salesforce CEO Marc Benioff's Biggest AI Fears
Salesforce Insider Sold Shares Worth $2,533,877, According to a Recent SEC Filing
Salesforce Is Maintained at Outperform by Wedbush
Salesforce Analyst Ratings
Growth Investor27 : Check out Esperion ESPR, it is a very cheap stock that sells newly FDA approved statin alternative drugs NEXLETOL and NEXLIZET . I take Nexlizet, my insurance just started covering it this month. Script sales will be very large
103138533 : !!!!!